Co-Stimulation Blockade as a New Strategy in Kidney Transplantation: Benefits and Limits

Author： Snanoudj Renaud Zuber Julien Legendre Christophe

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.16, 2010-11, pp. : 2121-2131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Blockade of TCR Signal Transduction and Co-Stimulation in Autoimmune Disease

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 2, 2005-04 ,pp. : 205-216

Bentham Science Publishers

Access to resources Recommend Favorite

Kidney Transplantation in Older Patients: Benefits and Risks

By Rao V.K.

Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. : 79-84

Adis International

Access to resources Recommend Favorite

Modulation of T-Cell Co-Stimulation in Rheumatoid Arthritis: Clinical Experience with Abatacept

By Laganà Bruno Vinciguerra Marta D'Amelio Raffaele

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 185-202

Adis International

Access to resources Recommend Favorite

Tofacitinib in kidney transplantation

By Wojciechowski David

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 9, 2013-09 ,pp. : 1193-1199

Informa Healthcare

Access to resources Recommend Favorite

Anesthetic Pharmacology for Kidney Transplantation

Current Clinical Pharmacology, Vol. 10, Iss. 1, 2015-04 ,pp. : 47-53

Bentham Science Publishers

Access to resources Recommend Favorite